Health care industry
FDA approves Merck drug for decimated U.S. cattle herds to stop screwworm
Cattle detained in the pens of the Chihuahua Regional Livestock Union , at the Jeronimo-Santa Teresa border crossing in Ciudad Juarez, Mexico on November 27, 2024, after the United States stopped imports of Mexican cattle due to the presence of screwworm. Anadolu | Anadolu | Getty Images U.S. cattle ranchers will soon have a new […]
Read More
Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company’s pill
Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021. John Thys | Reuters Pfizer on Tuesday said it has struck an […]
Read More
Bill Gates on why AI will become ‘hyper competitive’
Bill Gates talks to CNBC at Abu Dhabi Finance Week. CNBC Bill Gates has warned that some AI companies with high valuations will lose out in the “hyper competitive” AI industry, as the investors weigh up whether a bubble is about to burst. “AI is the most important thing going on,” the Microsoft founder and […]
Read More
RFK Jr.’s vaccine panel weakens recommendation on hepatitis B shot for babies, scrapping universal guidance
Dr. Vicky Pebsworth, from left, Massachusetts Institute of Technology professor Retsef Levi, Case Western Reserve University Professor Catherine Stein and Dr. Raymond Pollak, listen to presentations during an Advisory Committee on Immunization Practices (ACIP) meeting to discuss childhood vaccine schedule changes at the Centers for Disease Control and Prevention in Atlanta, Georgia, U.S., December 4, […]
Read More
RFK Jr.’s vaccine panel to vote on changing hepatitis B shot recommendation for babies
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. looks on as he attends a press conference to discuss health insurance reform, at the Department of Health and Human Services in Washington, D.C., U.S., June 23, 2025. Kevin Mohatt | Reuters Health and Human Services Secretary Robert F. Kennedy Jr.’s hand-picked vaccine committee […]
Read More
Jim Cramer has faith in Danaher’s turnaround as life sciences comes back to life
Life sciences stocks are seeing a resurgence — and that’s good news for Danaher . Connecting the dots to better times ahead for the struggling portfolio name, Jim Cramer thinks the industry turnaround is best illustrated by looking at Agilent Technologies ‘ recovery from a post-Covid rut. Shares are up around 50% from their April […]
Read More
‘Advice was so good,’ says CEO who used ChatGPT to pitch new ideas to AI versions of business icons
Joanna Stober, Midi Health CEO and co-founder, has never had an opportunity to run her business plans past legendary venture capital investor John Doerr, chairman at Kleiner Perkins. But that didn’t stop her from tapping Doerr, in an AI version, for advice on growing her startup, a virtual clinic offering midlife health care for women. […]
Read More
U.S. announces zero tariff pharmaceutical deal with Britain
U.S. President Donald Trump and British Prime Minister Keir Starmer hold a press conference following their meeting at Chequers, near Aylesbury, Britain, Sept. 18, 2025. Kevin Lamarque | Reuters The United States announced a deal with Britain for zero tariffs on pharmaceutical products and medical technology on Monday which will lead to Britain spending more […]
Read More
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the […]
Read More
Novo’s next-gen obesity drug shows positive results, heads to late-stage testing
The logo of Novo Nordisk is displayed at the 8th China International Import Expo. Sheldon Cooper | Lightrocket | Getty Images Novo Nordisk said on Tuesday its experimental obesity drug, amycretin, showed statistically significant weight loss of up to 14.5% at 36 weeks in patients with type 2 diabetes in a mid-stage study. The drugmaker’s […]
Read More